SM
GMED icon

SG3 Management’s Globus Medical GMED Stock Holding History

SG3 Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,000
Closed -$775K – 1088
2021
Q2 		$775K Buy
+10,000
New +$711K 0.03% 544
2021
Q1 		– Sell
-17,000
Closed -$1.11M – 1299
2020
Q4 		$1.11M Buy
+17,000
New +$977K 0.02% 533

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

SG3 Management's GMED Position: Q2 2022 in Review

SG3 Management sold out of Globus Medical (GMED) in Q2 2022, closing a stake of 1,000 shares — an estimated $74K sold.

SG3 Management first reported a position in GMED in Q1 2022 and held it in 1 quarter. The position peaked at $74K in Q1 2022. 364 funds tracked by Wall St. Rank hold GMED as of Q2 2022.

  • SG3 Management reported no remaining Globus Medical position as of Q2 2022 after selling out during the quarter.
  • SG3 Management sold 1,000 Globus Medical shares in Q2 2022, an estimated $74K.
  • SG3 Management first reported a position in Globus Medical in Q1 2022 and held it in 1 quarter.
  • SG3 Management's Globus Medical position peaked at $74K in Q1 2022.
  • 364 funds tracked by Wall St. Rank held Globus Medical as of Q2 2022.

Based on SG3 Management's 13F filing for Q2 2022, filed 15 Aug 2022.